Filter
52
Filtered Results: 52
Text search:
R.
Barnabas
Featured
Recommendations
7
New Publications
3
Language
Document type
Guidelines
26
Studies & Reports
13
No document type
10
Manuals
3
Countries / Regions
Burkina Faso
2
Malawi
2
Global
2
South Africa
2
Kenya
1
Lesotho
1
Mozambique
1
Africa
1
Latin America and the Carribbean
1
Tanzania
1
Brazil
1
Russia
1
Namibia
1
Ethiopia
1
Angola
1
Authors & Publishers
Publication Years
Category
Studies & Reports
6
COVID-19
3
Virology
3
Policies & Guidelines HIV & TB
2
Communicable Diseases
1
Hepatitis
1
Monitoring & Evaluation
1
NCD
1
Demograhic Health Surveys DHS
1
Policies
1
Guidelines
1
Drugs & Medical Equipment
1
Community Health
1
Capacity Building
1
Statistics
1
Respiratory Infections
1
Health Systems
1
Toolboxes
Diagnostics & Laboratory Guidance
15
Genomic sequencing
6
Surveillance & Contact tracing
5
HIV testing & services
4
Laboratory Guidance
3
Clinical Guidelines
3
Children & Adolescents
2
Public Health
2
Studies & Reports
2
Reports & Studies
2
Eastern and Southern Africa
2
Agriculture & Veterinary
1
Clinical Aspects
1
HIV testing & disclosure
1
Hepatitis
1
Global
1
Discrimination & Stigma
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Public Health
1
Training, others
1
Country specific documents
1
Common Good
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Hospital Readiness/Essential Health Services
1
Nurses
1
Planetary Health
1
Agriculture
1
Women
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Reports & Studies Children HIV
1
Defending Rights
Breaking Barriers
Reaching People with HIV Services
Global Aids Update 2019
BMC Public Health, Volume 18, Article number: 303 (2018)
https://doi.org/10.1186/s12889-018-5208-0
Published: 02 March 2018
UNAIDS 2016, Reference
HIV care and support taking into account the 2016 WHO consolidated guidelines
Journal of the International AIDS Society, vol. 21 Issue no. 6 e 25142
Weaknesses in care programmes providing anti‐retroviral therapy (ART) persist and are often instigated by late HIV diagnosis and poor linkage to care. We investigated the potential for a home‐based counselling and testin...
Weaknesses in care programmes providing anti‐retroviral therapy (ART) persist and are often instigated by late HIV diagnosis and poor linkage to care. We investigated the potential for a home‐based counselling and testin...
2006-2008 programme report
Choko AT et al. Journal of the International AIDS Society 2017, 20:21610 http://www.jiasociety.org/index.php/jias/article/view/21610 | http://dx.doi.org/10.7448/IAS.20.1.21610
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Previous studies have highlighted a range of individual determinants associated with HIV testing but few have assessed the role of contextual factors. The objective of this paper is to examine the influence of both individual and community-level determinants of HIV testing uptake in Burkina Faso.
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
To evaluate the epidemiological evolution of patients with HIV (PtHIV), between 2002 and 2012, in a day-hospital that became an HIV reference centre for south-west Burkina Faso.
This was a retrospective study of PtHIV followed in the Bobo Dioulasso university hospital since 2002. The study was ba...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de...
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an...
Updated Treatment Guidelines
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...
